Sign in

CIK 0001509261

  • Non-accelerated filer
  • Smaller reporting company

Rezolute, Inc.

Sign in to watch
Ticker
RZLT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Jun 30
Incorporated
NV
Entity type
Operating
EIN
273440894
Phone
+1 650-206-4507
Business address
275 SHORELINE DRIVE, SUITE 500, REDWOOD CITY, CA, 94065
Former names
AntriaBio, Inc., FITS MY STYLE INC
  1. 4 Open-market buy CFO bought 20,000 shares at an average $2.89 ($57,700)
  2. 4 Derivatives Options or other derivatives
  3. 3 Insider Initial Statement of Ownership
  4. 4 Open-market buy Director bought 10,000 shares at $4.70 ($47,000)
  5. 4 Grant or award Director acquired 25,500 shares (grant or award)
  6. 4 Grant or award CFO acquired 77,000 shares (grant or award)
  7. 4 Grant or award Director acquired 25,500 shares (grant or award)
  8. 4 Open-market buy Director bought 1,250,000 shares at $4.00 ($5,000,000)
  9. 4 Grant or award Chief Medical Officer acquired 77,000 shares (grant or award)
  10. 4 Grant or award CEO acquired 204,000 shares (grant or award)
  11. 4 Grant or award Director acquired 25,500 shares (grant or award)
  12. 4 Open-market buy CFO bought 10,000 shares at $4.29 ($42,900)
  13. 4 Open-market buy CFO bought 9,000 shares at $4.60 ($41,400)
  14. 4 Open-market buy CFO bought 10,549 shares at $5.04 ($53,167)
  15. 4 Open-market buy Director bought 4,259 shares at $4.70 ($20,017)
  16. 4 Derivatives Options or other derivatives
  17. 4 Open-market buy Director bought 4,815 shares at $4.15 ($19,982)
  18. 4 Open-market buy Chief Medical Officer bought 7,600 shares at an average $3.91 ($29,743)
  19. 4 Open-market buy CFO bought 40,000 shares at $4.04 ($161,568)
  20. 4 Open-market buy CFO bought 451 shares at $3.50 ($1,579)

Page 3 of 11 · 208 filings